High-sensitive CRP as a predictive marker of long-term outcome in juvenile idiopathic arthritis
- 322 Downloads
To evaluate whether C-reactive protein (CRP), including variation within the normal range, is predictive of long-term disease outcome in Juvenile Idiopathic Arthritis (JIA). Consecutive patients with newly diagnosed JIA were included prospectively from defined geographic areas of the Nordic countries from 1997 to 2000. Inclusion criteria were availability of a baseline serum sample within 12 months after disease onset and 8-year clinical assessment data. Systemic onset JIA was not included. CRP was measured by high-sensitive ELISA (detection limit of 0.2 mg/l). One hundred and thirty participants with a median follow-up time of 97 months (range 95–100) were included. At follow-up, 38% of the patients were in remission off medication. Absence of remission was associated with elevated level of CRP at baseline (odds ratio (OR) 1.33, confidence interval (CI) 1.08–1.63, p = 0.007). By applying a cutoff at the normal upper limit (>10 mg/l), the risk of not achieving remission was increased to an OR of 8.60 (CI 2.98–24.81, p < 0.001). Variations of CRP within the normal range had no predictive impact on disease activity at follow-up. Baseline levels of ESR were available in 80 patients (61%) and elevated ESR was associated with absence of remission in a multivariable logistic regression analysis (OR 2.32, CI 1.35-4.00, p = 0.002). This results of this study indicate that baseline CRP concentrations above 10 mg/l are predictive of a poor outcome at 8-year follow-up. We could not demonstrate any predictive value of CRP variations within the normal range.
KeywordsArthritis Juvenile idiopathic High-sensitive CRP Erythrocyte sedimentation rate Follow-up
This work was supported by grants from the Department of Pediatrics, Naestved hospital, Region Zealand, the Research Department, Region Zealand, The Danish Arthritis foundation, and the Aase and Ejnar Danielsen Foundation.
- 14.Petty RE, Laxer RM, Lindsley CB, Wedderburn LR. Juvenile Idiopathic Arthritis. Textbook of Pediatric Rheumatology. 7 edn. Elsevier-Saunders, Philadelphia; 2016. 188–204Google Scholar
- 21.Sennels H, Sorensen S, Ostergaard M, Knudsen L, Hansen M, Skjodt H et al (2008) Circulating levels of osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor-kappa B ligand, and high-sensitivity C-reactive protein in patients with active rheumatoid arthritis randomized to etanercept alone or in combination with methotrexate. Scand J Rheumatol 37(4):241–247CrossRefPubMedGoogle Scholar
- 22.Hiura K, Iwaki-Egawa S, Kawashima T, Fujisawa S, Takeda T, Komori H et al (2013) The diagnostic utility of matrix metalloproteinase-3 and high-sensitivity C-reactive protein for predicting rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-negative patients with recent-onset undifferentiated arthritis. Rheumatol Int 33(9):2309–2314CrossRefPubMedGoogle Scholar
- 24.Gerss J, Roth J, Holzinger D, Ruperto N, Wittkowski H, Frosch M et al (2012) Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative study. Ann Rheum Dis 71(12):1991–1997CrossRefPubMedGoogle Scholar
- 25.De BF, Martini A (1998) Is systemic juvenile rheumatoid arthritis an interleukin 6 mediated disease? J Rheumatol 25(2):203–207Google Scholar
- 33.Hyrich KL, Lal SD, Foster HE, Thornton J, Adib N, Baildam E et al (2010) Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to paediatric rheumatology. Results from the Childhood Arthritis Prospective Study. Rheumatology (Oxf) 49(1):116–122CrossRefGoogle Scholar
- 34.Esbjornsson AC, Aalto K, Brostrom EW, Fasth A, Herlin T, Nielsen S et al. Ankle arthritis predicts polyarticular disease course and unfavourable outcome in children with juvenile idiopathic arthritis. Clin Exp Rheumatol 2015Google Scholar
- 37.Pelegrin L, Casaroli-Marano R, Anton J, Garcia de Vicuna MC, Molina-Prat N, Ignacio AJ et al (2014) Predictive value of selected biomarkers, polymorphisms, and clinical features for oligoarticular juvenile idiopathic arthritis-associated uveitis. Ocul Immunol Inflamm 22(3):208–212CrossRefPubMedGoogle Scholar
- 38.Guzman J, Oen K, Huber AM, Watanabe DK, Boire G, Shiff N et al. The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort. Ann Rheum Dis 2015Google Scholar